Immunohistochemical analysis of the TMA specimens of endometrial cancers was performed (Figures 3A–3D), and high EZH2 expression was significantly associated with poor PFS (P = 0.04) (Figure 3E) but not with OS (P = 0.2175) (Figure 3F). This evidence concerns the gene EZH2 and endometrial cancer.